1DYQ
STAPHYLOCOCCAL ENTEROTOXIN A MUTANT VACCINE
Summary for 1DYQ
Entry DOI | 10.2210/pdb1dyq/pdb |
Related | 1ESF 1SEA 1SXT |
Descriptor | Enterotoxin type A, ZINC ION, SULFATE ION, ... (4 entities in total) |
Functional Keywords | enterotoxin, staphylococcal enterotoxin type a, vaccine |
Biological source | Staphylococcus aureus |
Total number of polymer chains | 1 |
Total formula weight | 27417.02 |
Authors | Krupka, H.I.,Segelke, B.W.,Rupp, B. (deposition date: 2000-02-05, release date: 2001-03-19, Last modification date: 2024-11-13) |
Primary citation | Krupka, H.I.,Segelke, B.W.,Ulrich, R.,Ringhofer, S.,Knapp, M.,Rupp, B. Structural Basis for Abrogated Binding between Staphylococcal Enterotoxin a Superantigen Vaccine and Mhc-II? Protein Sci., 11:642-, 2002 Cited by PubMed Abstract: Staphylococcal enterotoxins (SEs) are superantigenic protein toxins responsible for a number of life-threatening diseases. The X-ray structure of a staphylococcal enterotoxin A (SEA) triple-mutant (L48R, D70R, and Y92A) vaccine reveals a cascade of structural rearrangements located in three loop regions essential for binding the alpha subunit of major histocompatibility complex class II (MHC-II) molecules. A comparison of hypothetical model complexes between SEA and the SEA triple mutant with MHC-II HLA-DR1 clearly shows disruption of key ionic and hydrophobic interactions necessary for forming the complex. Extensive dislocation of the disulfide loop in particular interferes with MHC-IIalpha binding. The triple-mutant structure provides new insights into the loss of superantigenicity and toxicity of an engineered superantigen and provides a basis for further design of enterotoxin vaccines. PubMed: 11847286DOI: 10.1110/PS.39702 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.5 Å) |
Structure validation
Download full validation report